Results

Total Results: 2,228 records

Showing results for "disease".

2101. PEPTIC ULCER #11 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1306.pdf
      June 01, 2013 - in this field focuses on drugs and biologics for irritable bowel syndrome and inflammatory bowel diseases … (e.g., Crohn’s disease, ulcerative colitis). … , biliary tract disease, and pancreatic disease while taking the drug. … National Digestive Diseases Information Clearinghouse (NDDIC). Short bowel syndrome. … Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National

2102. Survey of Medicare Part D Plans’ Medication Therapy Management Programs (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management-1_research-2007.pdf
      January 01, 2007 - Beneficiaries that qualify for MTM services are persons with multiple chronic diseases, on multiple … median number (range) of disease states were 3 (2-5). … Many programs further restricted enrollment by limiting the conditions from which the chronic diseases … Number of chronic diseases required for enrollment in a MTM program. … What are the disease requirements (number of diseases, specific diseases) for enrollees to be eligible

2103. Parathyroid Disorders | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/health-topics/parathyroid-disorders

2104. Seizures | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/health-topics/seizures

2105. Peripheral Nerve Disorders | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/health-topics/peripheral-nerve-disorders

2106. Urinary Incontinence | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/health-topics/urinary-incontinence

2107. Heroin | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/health-topics/heroin

2108. 15 Crosscutting Potential High Impact June 2012 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/15_crosscutting_potential_high_impact_june_2012.pdf
      January 01, 2012 - technologies are needed that could improve patient adherence with medication dosages for chronic disease … specificity and sensitivity, would actually translate to improved patient-centered outcomes, such as disease … [With this intervention,] better disease state management could occur.” 25 However, two other experts … develop rural communities’ “capacity for safe and effective treatment of chronic, common, and complex disease … model to address the problem of hepatitis C virus (HCV) infection in New Mexico and have used that disease

2109. Data-Points-7-Tables1 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/data-points-7-tables1.pdf
      May 29, 2025 - and Race Note: An asterisk (*) signifies a small cell count (less than 11); ESRD = end stage renal disease

2110. Methods Research Report Improving Access To And Usability of Systematic Review Data for Health Systems Guideline Development (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-health-systems-guidelines-development.pdf
      February 01, 2019 - Archives of Disease in Childhood. 2004;89(5):469-71. doi: 10.1136/adc.2003.029413. 49.

2111. Autism-Update Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism-update_executive.pdf
      August 01, 2014 - In addition, this review will be of use to the National Institutes of Health, Centers for Disease Control

2112. FRN 35 - Preventive Pharmacological Treatments for Migraine in Adults: Future Research Needs (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-future_research.pdf
      April 01, 2013 - In addition to chronicity, other disease characteristics vary as well. … In addition to chronicity, other disease characteristics vary as well. … A sample with diverse disease characteristics will be necessary. … Population Adults with chronic migraine with diverse disease characteristics. … Migraine prevalence, disease burden, and the need for preventive therapy.

2113. Disposition of Comments Report for Imaging Techniques for Treatment Evaluation for Metastatic Breast Cancer (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-imaging_disposition-comments.pdf
      October 01, 2014 - Page 13 line 46-47: Bone scintigraphy and PET/CT do not assess the same extent of disease and therefore … Imaging is used to diagnose metastatic disease (and then a biopsy is indicated) and also used to follow … This is an important group for whom the disease is indolent and particularly challenging to follow … Background Well done save the context of the challenge of imaging bone and more indolent disease. … While the use of fluoride bone scans is increasing for determining disease extent, we did not find any

2114. Methods-Guidance-Applicability Methods (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-applicability_methods.pdf
      January 01, 2011 - evidence of the benefits of aspirin for prevention of cardiovascular events from patients with heart disease … . 74.7 years) and more likely to be male (75% vs. 42%) than Medicare patients with cardiovascular disease … rheumatoid arthritis used radiographic progression rather than symptoms.25 Trials of Alzheimer’s disease … to most community populations.21 Clinical experts, population based surveys, outcome studies, and disease … Trial (including date, setting) Population Demographic, Disease state Intervention Comparator

2115. Methods Guide Atkins (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/methods_guide_atkins.pdf
      January 01, 2011 - evidence of the benefits of aspirin for prevention of cardiovascular events from patients with heart disease … . 74.7 years) and more likely to be male (75% vs. 42%) than Medicare patients with cardiovascular disease … rheumatoid arthritis used radiographic progression rather than symptoms.25 Trials of Alzheimer’s disease … to most community populations.21 Clinical experts, population based surveys, outcome studies, and disease … Trial (including date, setting) Population Demographic, Disease state Intervention Comparator

2116. Use of Analytic Hierarchy Process to elicit stakeholder preferences for prioritizing research (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/mcda-krishnan.pdf
      August 27, 2012 - Chronic obstructive pulmonary disease (COPD) as a key health condition. 2. … Slide 3 Chronic Obstructive Pulmonary Disease (COPD) • Key health condition in US – Most common … lung disorder • 24,000,000 persons – 3rd leading cause of death • Deaths rising • Heart disease … called Public Health Strategic Framework for CPOD Prevention Slide 4 Chronic Obstructive Pulmonary Disease

2117. Dementia-Agitation-Aggression Research-Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/dementia-agitation-aggression_research-protocol.pdf
      November 13, 2014 - those 70 and older suffer from dementia.3 Dementia is one of the most challenging and costly to treat diseases … Thies W, Bleiler L. 2013 Alzheimer's disease facts and figures. … Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. … Work Group on Alzheimer's Disease and other Dementias, Rabins PV, Blacker D, et al. … American Psychiatric Association Work Group on Alzheimer's Disease and other Dementias.

2118. The Role of Immunotherapy and the Management of Asthma: Systematic Review (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy_research-protocol.pdf
      September 14, 2016 - of the intervention – Allergen-specific immunotherapy: Immunotherapy, as a treatment for allergic diseases … (immunotherapy[mesh] OR immunotherap*[tiab]) AND (asthma[mh] OR asthma[tiab]) NOT (“occupational diseases … Centers for Disease Control and Prevention. CDC. FastStats; 2016. … Advances in upper airway diseases and allergen immunotherapy. … Immunomodulation of allergic disease.

2119. Disposition of Comments for Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer: An Update of a 2008 Systematic Review (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_disposition-comments.pdf
      December 16, 2014 - Several papers have addressed this and especially for men with low PSA/low risk disease outcomes NOT … ...3) future RCTs. of early intervenion should target higher PSA/higher risk disease as CER or vs. … Both sections say AS should be offered to men with “low risk” disease. … I am not sure why men with T3 disease were excluded form analysis 5. … We recognize that some patients thought to have T2 disease are found to have more advanced disease

2120. S89 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/s89.pdf
      October 01, 2007 - Research Design: The Centers for Disease Control and Prevention (CDC)-sponsored Vaccine Safety Datalink … surveillance systems, including the Vac- cine Adverse Events Reporting System (VAERS) of the Centers for Disease … Supported by the Vaccine Safety Datalink Project, Centers for Disease Control and Prevention, and the … Secular trends in disease, or in diag- nostic or coding practices, may lead to false signaling or failure … Centers for Disease Control and Prevention (CDC).